Â¥
4.15
Jul 2
Business Description
Beihai Gofar Chuanshan Biological Co Ltd
NAICS : 325414
SIC : 2836
ISIN : CNE000001DD2
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.42 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.18 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 7.19 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.9 | |||||
3-Year Book Growth Rate | 0.2 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.87 | |||||
9-Day RSI | 51.07 | |||||
14-Day RSI | 44.5 | |||||
6-1 Month Momentum % | -6.1 | |||||
12-1 Month Momentum % | 9.48 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.09 | |||||
Quick Ratio | 2.6 | |||||
Cash Ratio | 0.8 | |||||
Days Inventory | 116.93 | |||||
Days Sales Outstanding | 242.04 | |||||
Days Payable | 109.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | -0.04 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 23.85 | |||||
Operating Margin % | -6.41 | |||||
Net Margin % | -25.91 | |||||
FCF Margin % | -5.84 | |||||
ROE % | -10.11 | |||||
ROA % | -8.41 | |||||
ROIC % | -2.87 | |||||
ROC (Joel Greenblatt) % | -30.41 | |||||
ROCE % | -9.5 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.92 | |||||
PB Ratio | 2.53 | |||||
Price-to-Tangible-Book | 3.46 | |||||
EV-to-EBIT | -23.4 | |||||
EV-to-EBITDA | -23.4 | |||||
EV-to-Revenue | 5.79 | |||||
EV-to-FCF | -97.61 | |||||
Price-to-Projected-FCF | 6.19 | |||||
Price-to-Median-PS-Value | 0.95 | |||||
Price-to-Net-Current-Asset-Value | 6.59 | |||||
Earnings Yield (Greenblatt) % | -4.27 | |||||
FCF Yield % | -0.95 | |||||
Forward Rate of Return (Yacktman) % | -25.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Beihai Gofar Chuanshan Biological Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 355.148 | ||
EPS (TTM) (Â¥) | -0.174 | ||
Beta | 0.12 | ||
Volatility % | 24.79 | ||
14-Day RSI | 44.5 | ||
14-Day ATR (Â¥) | 0.149263 | ||
20-Day SMA (Â¥) | 4.116 | ||
12-1 Month Momentum % | 9.48 | ||
52-Week Range (Â¥) | 3.2 - 5.45 | ||
Shares Outstanding (Mil) | 524.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Beihai Gofar Chuanshan Biological Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Beihai Gofar Chuanshan Biological Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Beihai Gofar Chuanshan Biological Co Ltd Frequently Asked Questions
What is Beihai Gofar Chuanshan Biological Co Ltd(SHSE:600538)'s stock price today?
When is next earnings date of Beihai Gofar Chuanshan Biological Co Ltd(SHSE:600538)?
Does Beihai Gofar Chuanshan Biological Co Ltd(SHSE:600538) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |